VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BLLN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BLLNBillionToOne, Inc.
$97.50$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. BLLN
  4. Financial Ratios

BillionToOne, Inc. (BLLN) Financial Ratios

Latest Ratios: P/E Ratio 106.1x · EV/EBITDA 67.8x · ROE 2.3%. (2023–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

BLLN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023
Market Cap$4.5B$1.7B——
Enterprise Value$4.1B$1.4B——
P/E Ratio →106.07584.57——
P/S Ratio10.275.69——
P/B Ratio4.313.62——
P/FCF132.28110.57——
P/OCF182.3470.65——

P/E links to full P/E history page with 30-year chart

BLLN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023
EV / Revenue—4.43——
EV / EBITDA67.8248.35——
EV / EBIT255.72171.94——
EV / FCF—85.94——

BLLN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023
Gross Margin68.3%68.3%53.0%24.1%
Operating Margin5.3%5.3%-30.9%-96.9%
Net Profit Margin2.4%2.4%-27.2%-115.3%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023
ROE2.3%2.3%-41.9%-271.3%
ROA1.6%1.6%-16.8%-43.1%
ROIC13.5%13.5%-42.8%-65.5%
ROCE3.7%3.7%-23.7%-55.7%

BLLN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023
Debt / Equity0.230.230.654.80
Debt / EBITDA3.903.90——
Net Debt / Equity—-0.81-0.491.61
Net Debt / EBITDA-13.86-13.86——
Debt / FCF—-24.63——
Interest Coverage82.6782.67-16.41-24.27

Net cash position: cash ($496M) exceeds total debt ($109M)

BLLN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023
Current Ratio11.6911.698.031.73
Quick Ratio11.3211.327.721.62
Cash Ratio10.3410.346.751.46
Asset Turnover—0.480.510.37
Inventory Turnover5.515.518.217.56
Days Sales Outstanding—49.7959.1146.26

BLLN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023
Dividend Yield————
Payout Ratio————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023
Earnings Yield0.9%0.2%——
FCF Yield0.8%0.9%——
Buyback Yield0.0%0.0%——
Total Shareholder Yield0.0%0.0%——
Shares Outstanding—$21M$10M$45M

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Thin margins versus rapid growth

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q3)

Premium Multiples Price in Sustained Growth

Based on reported figures, BLLN trades at 119.92 times trailing earnings and 77.52 times EV/EBITDA, multiples that far exceed the peer group median and imply the market is capitalizing a durable growth trajectory well beyond current profitability.

A trailing P/E near 120 and a forward P/E of 142 imply that earnings are expected to grow rather than compress, since the forward multiple is higher, which is unusual and may reflect the market discounting near-term margin conversion. Compared with ILMN at 36.6 and PGNY at 32.6, BLLN's valuation rests almost entirely on sustaining revenue growth, leaving little room for error if deceleration arrives faster than expected. Investors should monitor whether operating margin expansion can keep pace with the multiple.

Gross Margin Strength Masks Thin Conversion

As reported in the financial statements, BLLN's gross margin of 70.9% in 2026Q3 is strong, yet operating margin of 9.0% and net margin of 14.1% remain modest for a business growing above 100% year over year on a trailing basis.

The gap between gross margin near 71 percent and operating margin of 9.0% indicates that sales, R&D, and clinical adoption spending absorb most of the gross profit, which is consistent with a company still investing aggressively in growth. The net margin exceeding operating margin in the latest quarter appears to reflect non-operating or tax effects rather than core earnings power, so operating margin is the more reliable indicator of earning power here. Operating leverage has improved from negative 32.9% in 2024Q3, but has not yet reached a level that would confirm durable profitability.

Returns Recovering From Deeply Negative Base

According to recent SEC filings, BLLN's ROIC climbed from negative 2.0% in 2025Q1 to 13.0% in 2026Q1 before settling at 6.0% in 2026Q3, a trajectory that signals recovery but not yet a stable compounding profile.

The move from negative to positive ROIC over five quarters reflects improving operating results rather than a shrinking capital base, since equity has grown substantially. ROE of 3.2% and ROA of 2.3% remain low, suggesting that the large cash balance is diluting returns on equity and assets. Investors should monitor whether ROIC can hold above a double-digit level as cash is deployed, since the current figures do not yet demonstrate durable value creation.

Low Leverage Anchored by Cash Position

As reported in the financial statements, BLLN's debt-to-equity of 0.25 and debt-to-EBITDA of 8.07 in 2026Q3 reflect modest reliance on borrowing, though EBITDA-based leverage is still elevated given thin reported earnings.

A debt-to-equity ratio near 0.25 suggests the capital structure is weighted toward equity, and total debt of $140.4M is well covered by $561.5M in cash, implying a net cash position. Interest coverage of 2,899.67 times appears extraordinarily high, which may reflect minimal interest expense relative to operating income, but the figure is sensitive to small denominators and should be interpreted cautiously. Debt service appears comfortable on current figures, though the quality of EBITDA as a coverage base warrants further investigation.

Cash Accumulation May Overstate Financial Strength

Based on reported figures, the most commonly misapplied metric for BLLN is the current ratio of 11.25, which is inflated by cash reserves and obscures the company's negative retained earnings of -$231.3M and volatile quarterly cash conversion.

Diagnostic and research businesses with large cash balances often present headline liquidity ratios that look exceptional without reflecting operating efficiency, and the 11.25 current ratio is driven largely by $561.5M in cash rather than by operating assets. A more informative approach is to examine free cash flow margin trends and operating cash conversion alongside net cash, since these capture whether earnings translate into cash. The volatile series ranging from negative 23.4% to 10.1% FCF margin suggests the recent inflection may prove less durable than the latest quarter implies.

Download Financial Ratios Data

Includes 30+ ratios · 3 years · Updated daily

Consensus & Technical Research Suite
Open BLLN Terminal

BLLN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BLLN — Frequently Asked Questions

Quick answers to the most common questions about buying BLLN stock.

What is BillionToOne, Inc.'s P/E ratio?

BillionToOne, Inc.'s current P/E ratio is 106.1x. This places it at the 50th percentile of its historical range.

What is BillionToOne, Inc.'s EV/EBITDA?

BillionToOne, Inc.'s current EV/EBITDA is 67.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 48.4x.

What is BillionToOne, Inc.'s ROE?

BillionToOne, Inc.'s return on equity (ROE) is 2.3%. The historical average is -103.7%.

Is BLLN stock overvalued?

Based on historical data, BillionToOne, Inc. is trading at a P/E of 106.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are BillionToOne, Inc.'s profit margins?

BillionToOne, Inc. has 68.3% gross margin and 5.3% operating margin.

How much debt does BillionToOne, Inc. have?

BillionToOne, Inc.'s Debt/EBITDA ratio is 3.9x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.